- Andrew Keniry, Natasha Jansz, Linden J. Gearing, Iromi Wanigasuriya, Joseph Chen, Christian M. Nefzger, Peter F. Hickey, Quentin Gouil, Joy Liu, Kelsey A. Breslin, Megan Iminitoff, Tamara Beck, Andres Tapia del Fierro, Lachlan Whitehead, Andrew Jarratt, Sarah A. Kinkel, Phillippa C. Taberlay, Tracy Willson, Miha Pakusch, Matthew E. Ritchie, Douglas J. Hilton, Jose M. Polo, Marnie E. Blewitt. BAF complex-mediated chromatin relaxation is required for establishment of X chromosome inactivation. Nature Communications, 2022; 13 (1) DOI: 10.1038/s41467-022-29333-1
The finding expands our understanding of how we switch genes on and off to make the different cell types in our bodies, as we develop in the womb.
It also offers a new way to potentially harness gene silencing in the future, to treat or reverse the progression of a broad range of diseases including cancer, congenital and infectious diseases.
Gene silencing is regulated by how tightly DNA is packed into a cell. The findings from a team led by Dr Andrew Keniry and Professor Marnie Blewitt reveal a new accordion-like trigger that is crucial to the process.
The research is published in Nature Communications.
All in the DNA
The DNA that makes up our genetic material is wrapped tightly around proteins, like thread wraps around a spool. When it is loosely packaged the genes can be switched on; when it is tightly compacted, genes are switched off.
In the new study, the researchers found that to switch a gene off, the DNA packaging must initially loosen up, before then being tightly compressed.
Professor Marnie Blewitt said discovering the accordion-style trigger took the team by surprise, changing their fundamental understanding to date of this critical process.
“We were amazed to learn that the DNA first needs to relax, to trigger this process,” she said.
“Similar to how an accordion needs to open up before it is compressed to elicit a musical note, we found our DNA needs to be opened up first, before it can be compressed and the gene is silenced.”
Dr Andrew Keniry said gene silencing had amazing therapeutic potential.
“If we could learn exactly how to switch genes off, we may one day be able to switch off detrimental genes in a variety of diseases,” Dr Keniry said.
“If you could switch off the oncogenes that drive cancer, for example, you potentially could have a new treatment.
“To be able to realise this dream, we first need to know how the process happens so it can be mimicked with medicines, and our discovery is one more vital piece of this puzzle.”
The fundamental mechanistic study was focused on efficiently searching for new factors involved in the gene silencing process.
To enable this, the team created a system they called ‘Xmas’, based on red and green tags that are normally switched off during development. The system reported gene activity from each X chromosome through the expression of a red and green fluorescent protein, to reveal if the gene silencing process was occurring normally.
The study uncovered a new molecular mechanism of gene silencing, with the researchers pinpointing the protein complex required for this process, known as the BAF complex.
The next steps for the research will investigate why the accordion effect is required for gene silencing and the relevance of the process for genes on other chromosomes, such as the autosomes.
This research was supported by the Dyson Bequest, the DHB Foundation, the Australian National Health and Medical Research Council, the Victorian State Government and a Bellberry-Viertel Senior Medical Research fellowship. The work also involved collaborations with other Australian researchers at Monash BioMedical Discovery Institute and The University of Tasmania.
We want to give thanks to the writer of this article for this outstanding web content
DNA discovery reveals a critical ‘accordion impact’ for switching off genes